News for AnGes, Inc. (AMGXF)

May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development...

The surge in demand for chest drainage catheters is mainly driven by several factors. These include the rising number of patients with cardiovascular...

Clinical trial data demonstrated Zokinvy treatment extended life by an average of 4.3 years in children and young adults with Hutchinson-Gilford progeriaEiger to receive $500,000 approval milestone...

Eiger BioPharmaceuticals, Inc. announced that it and its partner AnGes, Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy , a treatment for...

/PRNewswire/ -- DelveInsight's Atherosclerotic Cardiovascular Disease Market Insights report includes a comprehensive understanding of current treatment...

ROUYN-NORANDA, Quebec, Sept. 13, 2023 (GLOBE NEWSWIRE) —

/PRNewswire/ -- DelveInsight's Peripheral Artery Disease Market Insights report provides the current and forecast market analysis, individual leading...

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

/PRNewswire/ -- DelveInsight's Atherosclerosis Market Insights report includes a comprehensive understanding of current treatment practices, atherosclerosis...

July 24, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO AnGes Clinical Research Laboratory has...

July 18, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Begin contracted expanded newborn...

Read Brickell Biotech (NASDAQ:BBI) & AVROBIO (NASDAQ:AVRO) Financial Comparison at ETF Daily News

/PRNewswire/ -- One of the key trends in the degenerative disc disease market is the launch of innovative products. Technologically advanced products are more...

Read Financial Contrast: Palisade Bio (NASDAQ:PALI) and Brickell Biotech (NASDAQ:BBI) at ETF Daily News

Read Brickell Biotech (NASDAQ:BBI) vs. Aptose Biosciences (NASDAQ:APTO) Financial Review at ETF Daily News

Read Financial Comparison: Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) vs. Brickell Biotech (NASDAQ:BBI) at ETF Daily News

Read Financial Comparison: Brickell Biotech (NASDAQ:BBI) & Fusion Pharmaceuticals (NASDAQ:FUSN) at ETF Daily News

Read Head-To-Head Analysis: Brickell Biotech (NASDAQ:BBI) vs. BioCryst Pharmaceuticals (NASDAQ:BCRX) at ETF Daily News

/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...